You're BrowsingLos Angeles - DTLA

MedMen Receives Approval in New York For Lotions and Topical Sprays

July 31, 2018

LOS ANGELES (July 31, 2018) – MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB: MMNFF) announced today the New York Department of Health has approved MedMen’s request to manufacture and sell cannabis-infused lotions and topical pain-alleviating sprays for qualified medical marijuana patients.

MedMen’s four stores in New York currently offer vaporizer pens, tinctures and gel caps in five different formulations. Earlier this year, the state also approved MedMen adding ground flower in the form of metered pods to its product selection.

MedMen is one of only 10 companies licensed to manufacture and sell medical marijuana in New York. In April, MedMen opened its flagship store on Fifth Avenue, only one of three licensed dispensaries in Manhattan.

New York continues to expand its medical marijuana program. Recently, State Health Commissioner Howard Zucker filed emergency regulations allowing cannabis as a substitute for opioids, making medical marijuana legally accessible to patients currently using prescription opioids to treat severe pain.

MedMen operates a cultivation and manufacturing facility in Utica, New York and four dispensaries statewide. The company operates licensed facilities in California and Nevada, and recently signed a definitive agreement to acquire the assets of Florida-based Treadwell Nursery, including rights to open 25 stores in that state.

About MedMen:

MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations nationwide. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws. Visit

For further information, please contact:

Media Contact:

Briana Chester Senior Publicist E-mail: 1-424-888-4260

Investor Relations Contact:

Stéphanie Van Hassel Head of Investor Relations E-mail: 1-323-705-3025

What's Happening Now
Follow us